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Objective: We have reviewed the medical histories of 4 patients who underwent operations between November
2004 and February 2011 at Changhai Hospital for cardiac papillary fibroelastoma.
Methods: Diagnosis was demonstrably suggested by echocardiography. Tumor locations were mitral valve (1), left
atrium (1), and aortic valve (2). Indications for operation were previous cerebrovascular accident for the mitral
tumor, incidental apopsychia and giant mobile mass for the left atrium, ingravescent chest tightness and
palpitations for the first aortic tumor, and severe regurgitation of aortic valve for the second aortic tumor. The study
was approved by the Changhai Hospital Ethics Committee, and the consent from the patients or their immediate
family was obtained.
Results: Surgical excision with necessary valve replacement operations was performed in all cases. All patients had
uneventful postoperative recoveries. No evidence of regurgitation or recurrence was seen on echocardiography at
follow-up.
Conclusions: Despite their histologically benign aspect, cardiac papillary fibroelastomas should be removed
because of potential embolic complications.
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Cardiac papillary fibroelastoma (CPFE) is rarely in lite-
rature as a primary cardiac neoplasm of unknown pa-
thogen [1]. The incidence of primary cardiac tumors is
reported to be less than 0.3% in autopsy series, and ap-
proximately 50% of them are cardiac myxomas [2,3].
CPFE, taking the third place of the primary cardiac neo-
plasm, generally involves and damages the cardiac valves.
As previously documented, though many papillary fibroe-
lastomas may not cause symptoms, early diagnosis of
CPFE is of prior importance to prevent patients from
fatal complications [4].
We report 4 cases in this paper to demonstrate the
complications, pathological characteristics of CPFE and
the intraoperative findings.* Correspondence: markzhmi@gmail.com
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Patient 1: A 23-month-old baby girl was admitted to our
hospital for the treatment of an ingravescent right side
hemiplegia with prolonged low-grade fever. The patient
was diagnosed 3 months ago as 1. cerebral infarction,
acute right hemiplegia; 2. infective endocarditis; 3. respira-
tory tract infection. At cardiac examination, the patient
was in sinus rhythm while presenting a II/ 6 systolic mur-
mur in heart apex. Physical examination showed muscle
strength decrease, hypermyotonia and positive Babinski
sign in her right extremities. The right knee and tendo cal-
caneus reflexes hyperfunctioned. Transthoracic echocar-
diography revealed multiple mobile masses on the mitral
valve (Figure 1), left ventricle and left ventricular outflow
tract. The cranial computerized tomography revealed ce-
rebromalacia in the left parietal lobes, left temporal lobes,
left basal ganglia, right frontal parietal and right temporal
lobes (Figure 2). Electrocardiogram showed an old myo-
cardial infarction in inferior heart wall. Hemoculture
was negative. After an effective anti-infective therapy,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Preoperative echocardiography image of the CPFE
adherent to the mitral valve. MV: mitral valve.
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gical findings include multiple mobile masses attaching to
mitral valve and left ventricle and tubular sclerosis in the
distal part of left anterior descending artery. Neither pa-
tent ductus arterious nor other congenital cardiac anoma-
lies existed. The tumor and the mitral valve was excised
and replaced with an artificial heart valve. The following
histopathology examination confirmed the diagnosis of
a CPFE by gross image, hematoxylin-eosin and Victoria
blue-van Gieson staining.
Patient 2: A 70-year-old woman was referred in April
2nd, 2006 for the treatment of an ingravescent dyspnea,
palpitation and incidental apopsychia, especially arising
after exercises. These symptoms cannot be controlled
with an oral medication. The physical examination did
not revealed any noticeable abnormalities. TransthoracicFigure 2 CT revealed low density imaging in the left
parietal-temporal lobe, left basal ganglia and right frontal
parietal-temporal lobe.echocardiography revealed a comparatively hyperechoic
loosen mass (24 × 25 mm)in the left atrium attached
to the endocardium by a pedicle. Results of biologic,
electrocardiographic, chest radiographic, and abdominal
duplex ultrasonographic studies were all within normal
limits. An operation was performed on April 7, 2006.
Surgical findings consisted of a gelatinous mass, which is
attached to the left atrium endocardium near the left
auricle and a regurgitation of tricuspid valve. Papillary
fronds of the tumot are narrow elongated, and branching
(Figure 3). The patient underwent a tumorectomy along
with an aortic valve replacement and a tricuspid valvu-
loplasty. The patient’s postoperative course was unevent-
ful. The postoperative pathological studies confirmed the
diagnosis of CPFE.
Patient 3: A 60-year-old woman was referred in June
23rd, 2011 for the gradually developing chest tightness
and palpitations. The patient had an uneventful previous
medical history except for an atrial fibrillation. She had
been admitted to her local hospital because of previously
described symptoms while she was resting in 2006 and
2007. Results of preoperative studies were all within nor-
mal limits. The electrocardiographic showed an atrial
fibrillation. Meanwhile, the transthoracic echocardiogra-
phy revealed a mobile mass (approximate 6 × 6 mm)
attached to the left coronary valve accompanying atrio-
ventricular valves regurgitation and pericardial effusion.
The patient underwent a surgical resection in July 1st,
2011. The intraoperative finding consisted of a CPFE
(confirmed by histologic examination) adhered to the
free edge of the noncoronary aortic cusp. The tumor and
the aortic valve were removed. An aortic valve replace-
ment was then performed.
Patient 4: A 34-year-old woman was referred in
November 11th, 2004 for a cardiac murmur newly re-
vealed in a physical examination which is undertaken for
an acute upper respiratory tract infection. At admission,Figure 3 Gross image of a CPEF.
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in aortic valve auscultation II along with a diastolic
murmur in aortic valve auscultation. Transthoracic echo-
cardiography revealed 1. supracristal ventricular septal de-
fect (approximate 7 mm in diameter ); 2. aortic valve
malformation with severe regurgitation. The aortic valve
replacements combined with septal defect morioplasty
was accomplished on November 26th, 2004. Intraopera-
tive foundings accorded with the echocardiography diag-
nosis. The postoperative tissue biopsy showed a neoplasm
(around 2 mm in its greatest dimension), that is of a sea
anemone-like appearance with multiple papillary fronds
attached to the endocardium by a short pedicle. The
tumor with a single layer of endocardial cells covering the
papillary surface merged imperceptibly into the subendo-
thelium of the noncoronary cusp. Microscopically, the
hyperplastic compact collagen embedded in loose con-
nective tissue composed the core of this tumor. The elas-
tic fibers were irregular and fractured. In view of the
pathological foundings, a CPFE was diagnosed.
Conclusions
After Cheitlin et al. [5] defined this tumor as “papillary
fibroelastoma” for the first time, CPFE was sporadically
reported with an incidence between 0.002% and 0.33% at
autopsy ranging [6]. Male seems to be more vulnerable
[1]. However, it is contradicted that all of our 4 patients
are female. The tumor always occurs sporadically in allFigure 4 Histologic section of an excised CPFE. (a) CPFE has a distinctiv
papillaryfronds are covered by endothelial cells. (c, d) Elastic fiber varies inage groups, but it clearly predominates in adults. The
average age of diagnosis is around 60 [7]. It is extremely
rare in children. Therefore, the diagnosis of a CPFE in
infants and children is of vital importance due to a
higher risk for embolization in this age group [8]. Not-
ably, the youngest patient here is only around 2 years
old. Considering her uneventful past medical history, it
is quite evident to make a diagnosis of congenital CPFE.
Unfortunately, in this patient a cerebral embolization oc-
curred before the excision was performed.
Grossly, CPFE has a distinctive flower-like appearance
with multiple papillary fronds attached to the endocar-
dium by a short pedicle [9]. Papillary fronds are narrow
elongated, and branching. They merge imperceptibly
into the substance of the valve, and are easily visible
when immersed in water or saline solution to show a
distinctive sea anemone-like appearance, thus providing
easy morphological verification of the tumor being a
CPFE (Figure 3).
CPFE is a microscopically avascular papillomass
(Figure 4a) with a single layer of endocardial cells
covering the papillary surface (Figure 4b). Matrix consists
of proteoglycans and elastic fibers, but their distribution
could be variable. Elastic Victoria-blue and van Gieson
stain is especially useful for delineating these components
(Figure 4c, d).
Most CPFE are asymptomatic and found incidentally at
the time of routine physical examination, echocaidiography,e flower-like appearance with multiple papillary fronds. (b) The
tumor substance. (bar = 100 μm).
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usually develop on cardiac valves, but many arise any-
where else in the heart. It present with a great variety of
symptoms, especially cardiovascular in nature [7,10-13].
The clinical presentation is determined by many factors,
including tumor location, size, growth rate, and tendency
for embolization. The most common fetal complications
are caused by embolism to cerebral, systemic or coronary
arterial circulation, followed by heart failure and sudden
death [14-17]. In our review, emboli had led to cere-
brovascular and cardiovascular accident in Patient 1,
who presented a group of symptoms resembling in-
fective endocarditis.
Sun et al. [7] recommend the following management
of patients with CPFE: 1. In asymptomatic patients with
right-sided CPFE, a conservative strategy is acceptable
except for the large mobile tumors; 2. The presence with
a sizeable right-to-left shunt is a risk factor for right-
sided CPFE; 3. Asymptomatic patients with small, left-
sided, nonmobile CPFE are usually observed; 4. CPFE ≥
1 cm, especially, if mobile, should be considered for ex-
cision; 5. Patients with other cardiovascular disease, low
risk of surgery and a high risk for embolization is re-
commended for an operation. But, others argued, pro-
phylactic tumor excision with valve replacement when
necessary, even in asymptomatic patients, is considered
by many to be the treatment of choice [13,18].
In our experience, these tumors, even in asymptomatic
patients with small-sized, should be surgically managed.
Because even tiny CPFE can lead to stroke and other ir-
reversible complications, like in Patient 1. The severe
consequence indicates that in young patients, wherever
dose a CPFE locate, the surgical resection should be the
primary therapy strategy after careful evaluation to eli-
minate the life-long threaten of embolism. Mechanical
damage to a heart valve or adhesion of the tumor to valve
leaflets may call for valve repairmen or replacement.Consent
Written informed consent was obtained from the patients
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port and any accompanying images. A copy of the writ-
ten consent is available for review by the Editor-in-Chief
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